P&G May Choose Intrinsa, Nuvessa Or Adveon To Name Testosterone Patch
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Procter & Gamble may be considering the tradenames Intrinsa, Entrinsa, Intrensa, Nuvessa, and Adveon for its testosterone replacement patch therapy for female sexual dysfunction. The firm submitted the names to the Patent and Trademark Office for a transdermal hormone replacement patch.